The Prevalence of Gingival Pigmentation Among a Sample of Adult Egyptian Population. (NCT05453890) | Clinical Trial Compass
CompletedNot Applicable
The Prevalence of Gingival Pigmentation Among a Sample of Adult Egyptian Population.
Egypt374 participantsStarted 2022-10-01
Plain-language summary
This observational cross-sectional study aims at determining the prevalence of gingival pigmentation among a sample of adult Egyptian patients attending the diagnostic centre at Faculty of Dentistry, Cairo University and identifying its association with other risk factors.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients whose age is 18 years old and above.
* Patient consulting in the diagnostic centre, Faculty of Dentistry, Cairo University.
* Provide informed consent.
Exclusion Criteria:
* Systemic diseases and syndromes known to be associated with oral melanin pigmentation, such as Addison's disease, Albright's syndrome, Hereditary hemorrhagic telangiectasia, and HIV-associated melanosis (Peeran et al 2014).
* Patients taking certain drugs that predispose to drug-induced melanin pigmentation, such as: ACTH, Antimalarial drugs, and Chemotherapeutic agent-busulfan (Peeran et al 2014).
* Tattoos of the oral mucosa
* Patients having problem in opening their mouth or undergoing inter-maxillary fixation where oral examination will not be possible.
* Patients diagnosed with psychiatric problems.